An Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews: Volume Five: Neuropsychopharmacology

ISBN-13: 9781461161714 / Angielski / Miękka / 2011 / 456 str.

Thomas A. Ban M. D.; Samuel Gershon M. D.

Opis

THE SERIES The 10 volumes in this series record a fifty year history of neuropsychopharmacology related by 213 pioneer clinical, academic, industrial and basic scientists in videotaped interviews, conducted by 66 colleagues between 1994 and 2008. These volumes include a preface by the series editor placing its contents in an historical context and linking each volume to the next. Each volume is dedicated to a former President of the ACNP and edited by a distinguished historian or Fellow of the College who provides an introduction to its themes and a biography of each scientist's career. The series provides insights into a half century of discovery and innovation with its rewards and disappointments, progress and setbacks, including future expectations and hopes for the field as a whole and the ACNP as an organization. IN THIS VOLUME In the first nine volumes of this series the development of different areas of research in neuropsychopharmacology is told in the biographic interviews of those who contributed to this development. In Volume 10, the story of the American College of Neuropsychopharmacology (ACNP) is pieced together from extracts of these interviews. ACNP was founded in 1961 and will celebrate its 50s anniversary in November 2011. This series was released at the anniversary celebrations. Volume 10 includes also a Postscript supplemented with a chronological list of selected publications that provides an overview of the history of the field, as well as a list of quotations extracted from the transcripts. Dedicated to the Memory of J. Richard Wittenborn, President ACNP, 1973, Volume 10 was edited by Martin M Katz, a prominent psychopharmacologist with a distinguished career in research administration. Katz served as Executive Secretary of the first Advisory Committee on Psychopharmacology to the US National Institutes of Health.